Rituximab

Details

Files

Generic Name:

Rituximab

Project Status:

Complete

Therapeutic Area:

Arthritis, Rheumatoid

Manufacturer:

Hoffmann-La Roche Limited

Brand Name:

Rituxan

Project Line:

Reimbursement Review

Project Number:

SR0068-000

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Arthritis, Rheumatoid

Recommendation Type:

List with clinical criteria and/or conditions

Final Recommendation:

February 14, 2007

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Last Updated : June 26, 2006